Home Dialysis Services Peoria is a medicare approved dialysis facility center in Peoria, Illinois and it has 0 dialysis stations. It is located in Peoria county at 719 Main St, Peoria, IL, 61602. You can reach out to the office of Home Dialysis Services Peoria at (309) 966-0802. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Home Dialysis Services Peoria has the following ownership type - Profit. It was first certified by medicare in October, 2015. The medicare id for this facility is 142788 and it accepts patients under medicare ESRD program.
| Name | Home Dialysis Services Peoria |
|---|---|
| Location | 719 Main St, Peoria, Illinois |
| No. of Dialysis Stations | 0 |
| Medicare ID | 142788 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 719 Main St, Peoria, Illinois, 61602 | |
| (309) 966-0802 | |
| Not Available |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
| NPI Number | 1073799383 |
| Organization Name | Peoria Home Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 719 Main St Peoria, Illinois, 61602 |
| Phone Number | (309) 673-4208 |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
| NPI Number | 1275922890 |
| Doing Business As | Home Dialysis Services Peoria Llc |
| Address | 719 Main St Peoria, Illinois, 61602 |
| Phone Number | (309) 966-0802 |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 1 |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular peritoneal dialysis at the center | 8 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 45 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Home Dialysis Services Peoria with elevated calcium levels.
| Patients with hypercalcemia | 15 |
| Hypercalcemia patient months | 90 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 16 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 20 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 30 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 7 |
| Patient months included in arterial venous fistula and catheter summaries | 34 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 4 |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
Medical scientists at the University of Leicester are urgently tackling a rising tide of teenage dietary problems through an education programme for over 800 secondary school students.
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.
› Verified 3 days ago